About Index Trending news
Analyze
Top 50 Pricing
DBV Technologies

DBV Technologies

Work at DBV Technologies? Add yourself to this profile

DBV Technologies

DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$281,500,000
Venture capital (Series C)
$25,500,000
Sofinnova Partners, Alto Invest, ALK Abelló, +2
Employees

Unknown size

Locations
HQ
Headquarters
$25,500,000 Venture capital (Series C)
dowjones

DBV Technologies Raises $25.5M Series C For Peanut Allergy Patch

$281,500,000 Post-IPO equity
FinSMEs

DBV Technologies Closes $281.5M Public Offering | FinSMEs

$2,700,000 Venture capital (Series Undisclosed)
dowjones

DBV Raises Additional $2.7M To Develop Peanut Allergy Vaccine